Expression of FOXP1 and FOXO3a in extrahepatic cholangiocarcinoma and the implications in clinicopathological significance and prognosis

Aims: Extrahepatic cholangiocarcinoma (EHCC) is a highly malignant tumor with poor prognosis and intrinsic resistance to cytotoxic agents. The molecular mechanisms associated with high malignancy and resistance to chemotherapy and radiotherapy have not been fully elucidated. This study investigated...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Onco Targets Ther
Auteurs principaux: He, Jun, Yang, Zhulin, Wu, Zhengchun, Wang, Lingxiang, Xu, Shu, Zou, Qiong, Yuan, Yuan, Li, Daiqiang
Format: Artigo
Langue:Inglês
Publié: Dove 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489656/
https://ncbi.nlm.nih.gov/pubmed/31114239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S197001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires